MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$17,636K
Interest income
$2,070K
Loss from operations
-$19,706K
Total operating
expenses
$19,706K
Research and development
(including related party...
$14,379K
General and
administrative (including...
$5,327K
Back
Back
Income Statement
source: myfinsight.com
Design Therapeutics, Inc. (DSGN)
Design Therapeutics, Inc. (DSGN)